Usage of Percutaneous Left Ventricular Assist Devices in Clinical Practice and High-risk Percutaneous Coronary...

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Medical Device Technology

Background:

• Patients with poor left ventricular function and complex coronary anatomy face high risks with percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).
• Some high-risk patients are ineligible for surgery due to prior cardiac procedures or severe comorbidities.
• Limited treatment options exist for the highest-risk individuals requiring coronary revascularization.

Purpose of the Study:

• To review mechanical circulatory support systems and portable extracorporeal oxygenation for high-risk PCI patients.
• To discuss the hemodynamic and physiologic rationale for using these advanced devices.
• To outline indications, strategies, and evidence supporting their application in complex PCI.

Main Methods:

• Review of currently available mechanical circulatory support (MCS) systems.
• Examination of portable extracorporeal oxygenation (ECMO) technologies.
• Analysis of clinical evidence, indications, and application strategies for MCS and ECMO in high-risk PCI.

Main Results:

• Percutaneous left ventricular assist devices (pLVADs) are now approved and available, offering new therapeutic avenues.
• These devices provide hemodynamic support, enabling complex interventions in previously prohibitive cases.
• Evidence for the use of MCS and portable ECMO in high-risk PCI is emerging, demonstrating feasibility and potential benefits.

Conclusions:

• Percutaneous mechanical circulatory support devices represent a significant advancement for high-risk patients undergoing PCI.
• These technologies expand treatment options for individuals with poor left ventricular function and complex coronary anatomy.
• Further research and clinical experience are crucial to optimize the use of these devices in interventional cardiology.